Stanford University and UberCloud Achieve Breakthrough in Living Heart Simulations

By Wolfgang Gentzsch, UberCloud, and Francisco Sahli, Stanford University

September 21, 2017

Cardiac arrhythmia can be an undesirable and potentially lethal side effect of drugs. During this condition, the electrical activity of the heart turns chaotic, decimating its pumping function, thus diminishing the circulation of blood through the body. Some kind of cardiac arrhythmia, if not treated with a defibrillator, will cause death within minutes.

Before a new drug reaches the market, pharmaceutical companies need to check for the risk of inducing arrhythmias. Currently, this process takes years and involves costly animal and human studies. In this project, the Living Matter Laboratory of Stanford University developed a new software tool enabling drug developers to quickly assess the viability of a new compound. This means better and safer drugs reaching the market to improve patients’ lives.

This research project has been performed by researchers from the Living Matter Laboratory at Stanford University, and supported by Living Heart Project members from SIMULIA, Hewlett Packard Enterprise, Advania, and UberCloud. It is based on the development of a Living Heart Model (LHM) that encompasses advanced electro-physiological modeling. The end goal is to create a biventricular finite element model to be used to study drug-induced arrhythmias of a human heart.

The Living Heart Project is uniting leading cardiovascular researchers, educators, medical device developers, regulatory agencies, and practicing cardiologists around the world on a shared mission to develop and validate highly accurate personalized digital human heart models. These models will establish a unified foundation for cardiovascular in silico medicine and serve as a common technology base for education and training, medical device design, testing, clinical diagnosis and regulatory science —creating an effective path for rapidly translating current and future cutting-edge innovations directly into improved patient care.

The Stanford team in conjunction with SIMULIA have developed a multi-scale 3-dimensional model of the heart that can predict the risk of this lethal arrhythmias caused by drugs. The team added capabilities to the Living Heart Model to include highly detailed cellular models, to differentiate cell types within the tissue and to compute electro-cardiograms (ECGs). This model is now able to bridge the gap between the effect of drugs at the cellular level to the chaotic electrical propagation that a patient would experience at the organ level.

A computational model that is able to assess the response of new drug compounds rapidly and inexpensively is of great interest for pharmaceutical companies, doctors, and patients. Such a tool will increase the number of successful drugs that reach the market, while decreasing cost and time to develop them, and thus help hundreds of thousands of patients in the future. However, the creation of a suitable model requires taking a multiscale approach that is computationally expensive: the electrical activity of cells is modelled in high detail and resolved simultaneously in the entire heart. Due to the fast dynamics that occur in this problem, the spatial and temporal resolutions are highly demanding.

Figure 1: Tetrahedral mesh (left) and cube mesh (right)

During the preparation and Proof of Concept phase (UberCloud Experiment 196), we set out to build and calibrate the healthy baseline case, which we then used to perturb with different drugs. After creating the UberCloud software container for SIMULIA’s Abaqus 2017 and deploying it on the HPE server in the Advania cloud, we started refining the computational mesh which consisted of roughly 5 million tetrahedral elements and 1 million nodes. Due to the intricate geometry of the heart, the mesh quality limited the time step, which in this case was 0.0012 ms for a total simulation time of 5000 ms. After realizing that it would be very difficult to calibrate our model with such a big runtime, we decided to work on our mesh, which was the current bottleneck to speed up our model. We created a mesh that was made out of cube elements (Figure 1). With this approach, we lost the smoothness of the outer surface, but reduced the number of elements by a factor of ten and increased the time step by a factor of four, for the same element size (0.7 mm). With a much faster model, we were able to calibrate the healthy, baseline case, which was assessed by electro-cardiogram (ECG) tracing (Figure 2) that recapitulates the essential features.

Figure 2: ECG tracing for the healthy, baseline case

During the final production phase, we have adapted all features of the model to a finer mesh with now 7.5 million nodes and 250,000,000 internal variables that are updated and stored within each step of the simulation. We have run 42 simulations to study whether a drug causes arrhythmias or not. With all the changes above we were able to speed up one simulation by a factor of 27 which then (still) took 40 hours using 160 CPU cores on Advania’s HPE system equipped with latest Intel Broadwell E5-2683v4 nodes and Intel OmniPath interconnect. In these simulations, we applied the drugs by blocking different ionic currents in our cellular model, replicating what is observed in cellular experiments. For each case, we let the heart beat naturally and see if the arrhythmia is developed.

Figure 3: Evolution of the electrical activity for the baseline case (no drug) and after the application of Quinidine. The electrical propagation turns chaotic after the drug is applied, showing the high risk of Quinidine to produce arrhythmias.

Figure 3 shows the application of the drug Quinidine, which is an anti-arrhythmic agent, but it has a high risk of producing Torsades de Points, which is a particular type of arrhythmia. It shows the electrical transmembrane potentials of a healthy versus a pathological heart that has been widely used in studies of normal and pathological heart rhythms and defibrillation. The propagation of the electrical potential turns chaotic (Figure 3, bottom) when compared to the baseline case (Figure 3, top), showing that our model is able to correctly and reliably predict the anti-arrhythmic risk of commonly used drugs. We envision that our model will help researchers, regulatory agencies, and pharmaceutical companies rationalize safe drug development and reduce the time-to-market of new drugs.

Acknowledgement: The authors are deeply grateful for the support from Hewlett Packard Enterprise (the Sponsor), Dassault Systemes SIMULIA (for Abaqus 2017), Advania (providing HPC Cloud resources), and the UberCloud tech team for containerizing Abaqus and integrating all software and hardware components into one seamless solution stack.

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

Researchers Scale COSMO Climate Code to 4888 GPUs on Piz Daint

October 17, 2017

Effective global climate simulation, sorely needed to anticipate and cope with global warming, has long been computationally challenging. Two of the major obstacles are the needed resolution and prolonged time to compute Read more…

By John Russell

Student Cluster Competition Coverage New Home

October 16, 2017

Hello computer sports fans! This is the first of many (many!) articles covering the world-wide phenomenon of Student Cluster Competitions. Finally, the Student Cluster Competition coverage has come to its natural home: H Read more…

By Dan Olds

UCSD Web-based Tool Tracking CA Wildfires Generates 1.5M Views

October 16, 2017

Tracking the wildfires raging in northern CA is an unpleasant but necessary part of guiding efforts to fight the fires and safely evacuate affected residents. One such tool – Firemap – is a web-based tool developed b Read more…

By John Russell

HPE Extreme Performance Solutions

Transforming Genomic Analytics with HPC-Accelerated Insights

Advancements in the field of genomics are revolutionizing our understanding of human biology, rapidly accelerating the discovery and treatment of genetic diseases, and dramatically improving human health. Read more…

Exascale Imperative: New Movie from HPE Makes a Compelling Case

October 13, 2017

Why is pursuing exascale computing so important? In a new video – Hewlett Packard Enterprise: Eighteen Zeros – four HPE executives, a prominent national lab HPC researcher, and HPCwire managing editor Tiffany Trader Read more…

By John Russell

Student Cluster Competition Coverage New Home

October 16, 2017

Hello computer sports fans! This is the first of many (many!) articles covering the world-wide phenomenon of Student Cluster Competitions. Finally, the Student Read more…

By Dan Olds

Intel Delivers 17-Qubit Quantum Chip to European Research Partner

October 10, 2017

On Tuesday, Intel delivered a 17-qubit superconducting test chip to research partner QuTech, the quantum research institute of Delft University of Technology (TU Delft) in the Netherlands. The announcement marks a major milestone in the 10-year, $50-million collaborative relationship with TU Delft and TNO, the Dutch Organization for Applied Research, to accelerate advancements in quantum computing. Read more…

By Tiffany Trader

Fujitsu Tapped to Build 37-Petaflops ABCI System for AIST

October 10, 2017

Fujitsu announced today it will build the long-planned AI Bridging Cloud Infrastructure (ABCI) which is set to become the fastest supercomputer system in Japan Read more…

By John Russell

HPC Chips – A Veritable Smorgasbord?

October 10, 2017

For the first time since AMD's ill-fated launch of Bulldozer the answer to the question, 'Which CPU will be in my next HPC system?' doesn't have to be 'Whichever variety of Intel Xeon E5 they are selling when we procure'. Read more…

By Dairsie Latimer

Delays, Smoke, Records & Markets – A Candid Conversation with Cray CEO Peter Ungaro

October 5, 2017

Earlier this month, Tom Tabor, publisher of HPCwire and I had a very personal conversation with Cray CEO Peter Ungaro. Cray has been on something of a Cinderell Read more…

By Tiffany Trader & Tom Tabor

Intel Debuts Programmable Acceleration Card

October 5, 2017

With a view toward supporting complex, data-intensive applications, such as AI inference, video streaming analytics, database acceleration and genomics, Intel i Read more…

By Doug Black

OLCF’s 200 Petaflops Summit Machine Still Slated for 2018 Start-up

October 3, 2017

The Department of Energy’s planned 200 petaflops Summit computer, which is currently being installed at Oak Ridge Leadership Computing Facility, is on track t Read more…

By John Russell

US Exascale Program – Some Additional Clarity

September 28, 2017

The last time we left the Department of Energy’s exascale computing program in July, things were looking very positive. Both the U.S. House and Senate had pas Read more…

By Alex R. Larzelere

How ‘Knights Mill’ Gets Its Deep Learning Flops

June 22, 2017

Intel, the subject of much speculation regarding the delayed, rewritten or potentially canceled “Aurora” contract (the Argonne Lab part of the CORAL “ Read more…

By Tiffany Trader

Reinders: “AVX-512 May Be a Hidden Gem” in Intel Xeon Scalable Processors

June 29, 2017

Imagine if we could use vector processing on something other than just floating point problems.  Today, GPUs and CPUs work tirelessly to accelerate algorithms Read more…

By James Reinders

NERSC Scales Scientific Deep Learning to 15 Petaflops

August 28, 2017

A collaborative effort between Intel, NERSC and Stanford has delivered the first 15-petaflops deep learning software running on HPC platforms and is, according Read more…

By Rob Farber

Oracle Layoffs Reportedly Hit SPARC and Solaris Hard

September 7, 2017

Oracle’s latest layoffs have many wondering if this is the end of the line for the SPARC processor and Solaris OS development. As reported by multiple sources Read more…

By John Russell

US Coalesces Plans for First Exascale Supercomputer: Aurora in 2021

September 27, 2017

At the Advanced Scientific Computing Advisory Committee (ASCAC) meeting, in Arlington, Va., yesterday (Sept. 26), it was revealed that the "Aurora" supercompute Read more…

By Tiffany Trader

Google Releases Deeplearn.js to Further Democratize Machine Learning

August 17, 2017

Spreading the use of machine learning tools is one of the goals of Google’s PAIR (People + AI Research) initiative, which was introduced in early July. Last w Read more…

By John Russell

GlobalFoundries Puts Wind in AMD’s Sails with 12nm FinFET

September 24, 2017

From its annual tech conference last week (Sept. 20), where GlobalFoundries welcomed more than 600 semiconductor professionals (reaching the Santa Clara venue Read more…

By Tiffany Trader

Graphcore Readies Launch of 16nm Colossus-IPU Chip

July 20, 2017

A second $30 million funding round for U.K. AI chip developer Graphcore sets up the company to go to market with its “intelligent processing unit” (IPU) in Read more…

By Tiffany Trader

Leading Solution Providers

Amazon Debuts New AMD-based GPU Instances for Graphics Acceleration

September 12, 2017

Last week Amazon Web Services (AWS) streaming service, AppStream 2.0, introduced a new GPU instance called Graphics Design intended to accelerate graphics. The Read more…

By John Russell

Nvidia Responds to Google TPU Benchmarking

April 10, 2017

Nvidia highlights strengths of its newest GPU silicon in response to Google's report on the performance and energy advantages of its custom tensor processor. Read more…

By Tiffany Trader

EU Funds 20 Million Euro ARM+FPGA Exascale Project

September 7, 2017

At the Barcelona Supercomputer Centre on Wednesday (Sept. 6), 16 partners gathered to launch the EuroEXA project, which invests €20 million over three-and-a-half years into exascale-focused research and development. Led by the Horizon 2020 program, EuroEXA picks up the banner of a triad of partner projects — ExaNeSt, EcoScale and ExaNoDe — building on their work... Read more…

By Tiffany Trader

Delays, Smoke, Records & Markets – A Candid Conversation with Cray CEO Peter Ungaro

October 5, 2017

Earlier this month, Tom Tabor, publisher of HPCwire and I had a very personal conversation with Cray CEO Peter Ungaro. Cray has been on something of a Cinderell Read more…

By Tiffany Trader & Tom Tabor

Cray Moves to Acquire the Seagate ClusterStor Line

July 28, 2017

This week Cray announced that it is picking up Seagate's ClusterStor HPC storage array business for an undisclosed sum. "In short we're effectively transitioning the bulk of the ClusterStor product line to Cray," said CEO Peter Ungaro. Read more…

By Tiffany Trader

Intel Launches Software Tools to Ease FPGA Programming

September 5, 2017

Field Programmable Gate Arrays (FPGAs) have a reputation for being difficult to program, requiring expertise in specialty languages, like Verilog or VHDL. Easin Read more…

By Tiffany Trader

IBM Advances Web-based Quantum Programming

September 5, 2017

IBM Research is pairing its Jupyter-based Data Science Experience notebook environment with its cloud-based quantum computer, IBM Q, in hopes of encouraging a new class of entrepreneurial user to solve intractable problems that even exceed the capabilities of the best AI systems. Read more…

By Alex Woodie

Intel, NERSC and University Partners Launch New Big Data Center

August 17, 2017

A collaboration between the Department of Energy’s National Energy Research Scientific Computing Center (NERSC), Intel and five Intel Parallel Computing Cente Read more…

By Linda Barney

  • arrow
  • Click Here for More Headlines
  • arrow
Share This